Japer Therapeutics, Inc. Warrants (JSPRW) Net Income by Year
Japer Therapeutics, Inc. Warrants reported a net loss of $76 in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Japer Therapeutics, Inc. Warrants has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
JSPRW Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
JSPRW Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Japer Therapeutics, Inc. Warrants financials
Frequently Asked Questions
What was Japer Therapeutics, Inc. Warrants's net income in fiscal year 2025?
Japer Therapeutics, Inc. Warrants reported a net loss of $76 in fiscal year 2025.
How fast is Japer Therapeutics, Inc. Warrants's net income growing?
Japer Therapeutics, Inc. Warrants (JSPRW) reported a $71.3M net loss in fiscal year 2024 and a $76 net loss in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
How has Japer Therapeutics, Inc. Warrants's net income changed over the years?
Across the 6 fiscal years this page covers, Japer Therapeutics, Inc. Warrants (JSPRW) net income went from -$31.7M in fiscal year 2020 to -$76 in fiscal year 2025.
What was Japer Therapeutics, Inc. Warrants's net income in the most recent quarter?
Japer Therapeutics, Inc. Warrants (JSPRW) reported -$2.8M in net income in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Japer Therapeutics, Inc. Warrants (JSPRW) reported on that line in every period on record.